Riverhead Capital Management’s Pediatrix Medical MD Stock Holding History

Riverhead Capital Management’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.91M	Sell	84,289 -22,282	-21%	-$508K	0.07%	345
2019 Q2	$2.69M	Sell	106,571 -22,118	-17%	-$594K	0.1%	281
2019 Q1	$3.5M	Buy	128,689 +63,413	+97%	+$2.13M	0.14%	202
2018 Q4	$2.15M	Buy	65,276 +33,309	+104%	+$1.34M	0.1%	269
2018 Q3	$1.49M	Sell	31,967 -19,741	-38%	-$906K	0.05%	381
2018 Q2	$2.24M	Sell	51,708 -5,881	-10%	-$282K	0.09%	292
2018 Q1	$3.2M	Sell	57,589 -4,300	-7%	-$236K	0.13%	207
2017 Q4	$3.31M	Sell	61,889 -6,100	-9%	-$288K	0.14%	191
2017 Q3	$2.93M	Buy	67,989 +12,796	+23%	+$608K	0.14%	198
2017 Q2	$3.33M	Buy	55,193 +12,893	+30%	+$764K	0.17%	166
2017 Q1	$2.94M	Buy	42,300 +2,800	+7%	+$194K	0.16%	189
2016 Q4	$2.63M	Buy	+39,500	New	+$2.57M	0.16%	186

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PCP

P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Riverhead Capital Management's MD Position: Q3 2019 in Review

Riverhead Capital Management reduced its Pediatrix Medical (MD) stake by 21% in Q3 2019, selling an estimated $508K and leaving 84,289 shares worth $1.91M. The position accounts for 0.07% of the portfolio, ranked #345.

Riverhead Capital Management first reported a position in MD in Q4 2016 and has held it in 12 quarters since. The position peaked at $3.5M in Q1 2019. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

Riverhead Capital Management held 84,289 shares of Pediatrix Medical worth $1.91M as of Q3 2019.
Riverhead Capital Management sold 22,282 Pediatrix Medical shares in Q3 2019, an estimated $508K.
Pediatrix Medical made up 0.07% of Riverhead Capital Management's portfolio in Q3 2019, its #345 holding.
Riverhead Capital Management first reported a position in Pediatrix Medical in Q4 2016 and has held it in 12 quarters since.
Riverhead Capital Management's Pediatrix Medical position peaked at $3.5M in Q1 2019.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Riverhead Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.